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1011-91 The Duration of Obesity Contributes to a Resistance in 
Weight Loss Program 
Kazuko Masuo, Toshio Ogihara, Michael L. Tuck, Osaka University Graduate School of 
Medicine, Suits City Japan, Sepulveda VA Medical Center, Sepulveda, California. 
Background: We reported suppressions of sympathetic overactivity and hyperinsulinemia 
contribute to weight loss (WL)-induced blood pressure (BP) reduction. However, not all 
subjects who change their weight have this sensitivity to BP. To clarify the contribution of 
duration of obesity and frequency of WL trial to resistance in WL-inducad BP reduction, 
we conducted this study. Methods: BMI, BP, plasma norepinephrine (NE), insulin (INS) 
and leptin (LEP) were measured at entry and week 8 after WL program with a combina- 
tion of a low caloric diet and exercise in age- and BMI matched 4 groups. The 4 groups 
were, 1) 28 obese men whose obesity was sustained less than 1 yr and this WL program 
was 1st trial (S-1), 2) 31 obese men, more than 3 yrs and ls1 WL trial (L-l), 3) 22 obese 
men, less than 1 yr and more than 3rd WL trial (S-3), and 4) 21 obese men, more than 3 
yrs and more than 3rd WL trial (L-3). Results: A significant WL and a significant BP 
reduction were defined as more than 10% reduction in BMI or mean BP at 8 week. A sig- 
nificant WL was succeeded in 82% in S-1, 45%* in L-l, 32% in S-3 and 19%* in L-3 
(*P<0.05 vs S). In subjects who succeeded in WL, BP reduction was noted in 74% in S-1, 
50%* in L-l, 71% in S-3 and 25% in L-3. The decreases in BMI, mean BP, plasma NE, 
INS and LEP at week 8 in subjects who succeeded in WL were significantly greater than 
in subjects who failed in WL in all 4 study groups. The decreases in plasma NE and INS 
in S-1 were the greatest among the 4 study groups, and the %decraases in NE and INS 
atweek 8 were greater in order of S-1>S-3>L-1 >L-3. However, the decrease in LEP were 
similar among the 4 study groups who succeeded in WL, and the decrease in LEP in 
subjects who succeeded in WL was significantly greater than that in subjects who failed 
in WL. Conclusion: These results demonstrate that the subjects who have been obese in 
longer duration and who have tried to lose their weight more frequently, are resistant in 
WL and WL-induced BP reduction. The resistant subjects to WL or WL-inducad BP 
reduction have blunted suppression of sympathetic overectivlty and hyperinsulinemia 
compared with subjects who succeeded in WL. The duration of obesity appears to be a 
more important predictor of success in WL and WL-induced BP reduction. 
1011-92 The Relation of Blood Pressure to Cardiovascular 
Mortality in Different Age Groups Varies by Ethnicity 
Furcv Paultre, Lori Mosca, Columbia University College of Physicians & Surgeons, New 
York, New York. 
Background: The relative importance of blood pressure (BP) indices [systolic BP (SBP), 
diastolic BP (DBP), and pulse pressure (PP)] as predictors of cardiovascular disease 
(CVD) is debated and poorly defined in minority populations. We hypothesized that the 
relation between BP and CVD varies with aging as a function of ethnicity. 
Methods: We combined data from 24,963 whites and 5,127 blacks (11,005 men, 19,085 
women, aged 30 to 97 years) free of CVD and not on antihypertensive drug therapy at 
baseline exams from 9 US cohort studies (ARIC, Framingham cohort and offspring, 
NHANES, Rancho Bernado, Chadeston, Evan's County, San Antonio, and Tecumseh). 
During a mean follow-up time of 14 years 3,187 deaths were observed. Cox regression 
was used to examine the relationship between BP and CVD mortality adjusted for tradi- 
tional risk factors (age, gender, smoking, diabetes, cholesterol and body mass index). In 
each ethnic group, Wald Chi-square tests were used to compare and determine the sig- 
nificance of associations in 4 age groups: <40, 40 to 49, 50 to 59, and >60 years. 
Results: All BP indices were significant (p<0.0001) for all age groups in models contain- 
ing a single BP index. In whites <40 years of age DBP was a stronger predictor of CVD 
mortality than SBP or PP, whereas in the 3 older groups SBP was the strongest predictor. 
In blacks, SBP was the strongest predictor in all age groups. When SBP and DBP were 
considered jointly in the same model, DBP (p<0.001), but not SBP, was significantly 
associated with CVD mortality in whites age <40 years. Both DBP (p<0.0001) and SBP 
(p=0.05) were associated with CVD in whites 40 to 49 years of age. Only SBP 
(p<0.0001) was significantly associated with CVD in whites 50 to 59 and >60 years of 
age. In blacks, SBP (p<0.001), but not DBP, was associated with CVD mortality in all 4 
age groups. 
Conclusion: In blacks, but not in whites, SBP was a better predictor of CVD mortality 
than DBP or PP in all age groups. DBP was most predictive among younger whites in 
contrast o SBP, which was most predictive in older whites. These data show that ethnic- 
ity influences the effect of aging on the relation between BP and CVD mortality, suggest- 
ing that specific BP indices may be more useful in sub-populations. 
1011-93 Burden of Cerdiorenal Disease in the United States 
General Adult Population 
Alessandro Cataliotti. Margaret M. Redfield, Richard J. Rodeheffer, Denise M. Heublein, 
Sharon M. Saodberg, Steven J. Jacobsen, Kent R. Bailey, Douglas W. Mahoney, John C. 
Burnett, Jr., Mayo Clinic and Foundation, Rochester, Minnesota. 
Background: Chronic renal insufficiency (CRI) is a strong predictor of increased mortal- 
ity in the presence of congestive heart failure (CHF). In addition, CRI is a major contribut- 
ing factor to the progression of CHF as it is associated with chronic volume overload, 
accelerated atherosclerosis and hypertension. While the prevalence of hypertension and 
of CHF is increasing in the US, the prevalence of CRI was last documented by the 
Framingham study (1978-1984), which reported a prevalence of elevated serum craati- 
nine (SCr) of 8.9% in men and 8.0% in women. The goal of the current study was to doc- 
ument CRI in a general adult population in the US and utilize a more accurate measure 
of glomerular filtration rate (GFR) that is age, body weight and gender adjusted. 
Methods: From 1997 to 1999 medical history, physical examination and SCr were 
obtained in 1982 randomly selected residents of Olmsted County, MN 3 45 years (range 
45 - 96 years). GFR was calculated using the Cockroff Gault equation adjusting for age, 
gender and body weight in which CRI was defined as a GFR < 59 ml/min. 
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Results: In this random adult cohort, the prevalence of cardiovascular risk factors was 
coronary atherosclerosis, 12%, hypertension, 29.5% and diabetes mellitus, 7.5%. The 
prevalence of CRI was 22.8% when GFR was used for its detection. Utilization of SCr 
alone without age, gender and weight adjustments markedly underestimated the preva- 
lence of CRI at 3.3% in this random adult population. 
Conclusion: This study is the first since 1984 to report the prevalence of CRI in the gem 
eral adult US population. The prevalence of CRI may be underestimated when SCr is 
used for its detection as compared to a more accurate age, weight and gender calcula- 
tion of GFR. Importantly, the burden of CRI is significant and requires further studies to 
understand mechanisms for its high prevalence and treatment strategies for its control 
and prevention. 
1011-94 Phys ica l  Ac t iv i ty  in Relat ion to  Endothelial Dysfunction 
and Angiogenesis in Hypertension 
Dirk C. Felmeden, Charles G. Spencer, Andrew D. Blann, Gareth D. Beevers, Greoorv 
JI2, Haemostasis, Thrombosis, and Vascular Biology Unit, University Department of 
Medicine, City Hospital, Birmingham, United Kingdom. 
Background:. Hypertension is an important risk factor for cardiovascular disease. The 
latest guidelines recommend regular physical exercise as initial step or adjunct in the 
treatment of hypertension. We investigated the association between physical activity and 
the degree of hypertension, as well as the relation to indices of endothelial dysfunction 
and angiogenesis. 
Methods: We studied 234 patients with hypertension (198 males; mean age 64 years), 
who were compared with 60 age and sex-matched healthy controls. We assessed the 
patient's physical activity using the validated Baecke physical activity questionnaire. We 
measured flow-mediated dilatation (FMD) of the brachial artery and von Willebrand factor 
(vWf) as indices of endothelial dysfunction, whilst angiogenesis was assessed by mea- 
surement of plasma vascular endothelial growth factor (VEGF) and its soluble receptor 
(sFlt-1) [ELISA]. 
Results: Patients with high (_>median) physical activity were younger, and had lower 
mean diastolic blood pressure and CVA risk, when compared with those with low 
(<median) physical activity. Indices of endothelial dysfunction and angiogenesis were not 
significantly different. 
Conclusion: Physical activity scores in hypertensive patients are not significantly differ- 
ent from healthy normotensive controls, and there appears to be no relation to the abnor- 
mal processes of endothelial damage/dysfunction and angiogenesis seen in 
hypertensives. 
Results 
Controls (N=60) Hypertensives p-value <median Baecke_>median Baecke p-value 
(N=234) score (N=117) score (N=117) 
Age (years] 62 (8) 64 (8) 0.098 67 (7) 61 (8) <0.001 
Body Mass 25.8 (3.4) 29.2 (4.4) <0.001 29.2 (4.0) 29.2 (4.8) 0.961 
Index [kg/m2] 
male:female 46:14 198:36 0.114 97:20 101:16 0.469 
8BP [mmHg] 134 (14) 166 (17) <0.001 166 (18) 166 (16) 0,828 
DBP [mmHg] 80 (7) 90 (10) <0.001 91 (10) 89 (9) 0.041 
Physical Activity Score (Baecke questionnaire) 
work score 1.57 (0.91) 1.66 (0.91) 0.527 1.13 (0.40) 2.19 (1.05) <0:001 
sport score 2.24 (0.78) 2.40 (0.66) 0.118 2.03 (0.57) 2.78 (0.52) <0.001 
leisure score 2.69 (0.50) 2.71 (0.59) 0.890 2.43 (0.52) 2.98 (0.53) <0.001 
total score 6.57 (1.58) 6.77 (1.46) 0.353 5.61 (0.91) 7.92 (0.81) <0.001 
Indices of Endothelial Dysfunction 
FMD [%] 8.80 (2.3) 4.89 (1,62) <0.001 4.87 (1.85) 4.89 (1.38) 0.974 
GTN-MD [%] 20.7 (2,2) 17.4 (6.4) <0.001 17.6 (6.6) 17.2 (5,9) 0.728 
vWf [iU/dl] 95 (20) 134 (30) <0,001 138 (30) 131 (30) 0.162 
Indices of Angtogenseis 
VEGF[pg/ml] 125(40-213) 340(190-1300)<0.001 400(190-1500) 300(170-1300) 0.275 
sFIt-1 [ng/ml] 17.0 (10.0-33.0) 4,0 (1.5-14,0) <0,001 5.5 (1,4-12.5) 4.0 (1.5-13,5) 0.871 
1011-95 Role of Inflammatory and Hemostatic Mediators in 
Preclinical Endothelial Dysfunction: Relevance to High- 
Risk Patients With Hypertension 
Tomoo Furumoto. Satoshi Fujii, Naotaka Saito, Taisei Mikami, Akira Kitabatake, 
Hokkaido University, Sapporo, Japan. 
Hypertension, hypofibrinolysis and inflammation accelerate atherosclerosis. Decrease in 
flow-mediated dilation (FMD) of brachial artery reflects endothelial dysfunction. Media- 
tors of inflammation and hemostasis predict cardiovascular morbidity and mortality, but 
their relation to FMD remains unclear. Thus, correlation of FMD and plasma levels of 
inflammatory cytokines and hemostatic variables in high-risk hypertensive patients with 
subclinical inflammation were determined. FMD was assessed by high-resolution ultra- 
sound, and plasma levels of tissue-type plasminogen activator (t-PA), a sensitive index of 
endothelial damage, and tumor necrosis factor (TNF)-c~, an established marker of inflam- 
mation, were determined by ELISA in normotensives and hypertensives under treatment 
(n=119). Blood pressure of treated hypertensives (134 ± 20 (SD) / 80 ± 14 mmHg, n=67) 
was not significantly different from that of normotensives (133 ± 13 / 79 ± 11, n=52). 
However, FMD was significantly reduced in hypertensives (9.9 ± 5.8%) compared to nor- 
motensives (14.5 ± 7.6, p < 0.01). Nitroglycerine induced endothelium independent 
vasodilation was not altered in hypertensives (16.6 ± 5.5%) as compared to normoten- 
elves (17.0 ± 6.4). Plasma t-PA levels were increased in hypertensives (10.4 ± 4.2 ng/ml) 
compared to normotensives (8.4 ± 3.2, p < 0.05), indicating continued endothelial dam- 
age despite blood pressure reduction. Plasma TNF-c~ levels were increased in hyperten- 
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sives (1.8 ± 1.2 pg/ml) compared to normotensives (1.3 ± 0.9, p < 0.05), indicating 
persistent inflammation. The association between FMD and t-PA and TNF-~ remained 
significant after adjustments for cardiovascular isk factors. Thus, inflammatory and pro- 
thrombotic mediators play a role in the pathogenesis of atherosclerosis over and above 
the effects of classic risk factors. Antihypertensive therapy alone may be insufficient o 
improve endothelial dysfunction in hypertensives with high plasma levels of inflammatory 
markers. Additional therapy to target inflammation may be necessary to improve endot- 
helial function and to prevent progression of coronary atherosclerosis in high-risk hyper- 
tensives with subclinical inflammations. 
1011-96 Lipid Profile of Hypertensive Patients With 
Hyperl ipldemla and Coronary Artery Disease After 
Treatment With Nebivoloh A Beta-Blocker With 
Enhanced Nitric Oxide Release 
Rahul Aorawal. Albert Lichtenthal, Carsten Milbredt, Cardiopulmonary Department, 
Berlin.Chemie AG, Menarini Group, Berlin, Germany. 
Background: Antihypertensive therapy should ideally reduce LDL- and increase HDL-lev- 
els in hypertensive patients prone for cardiovascular disease. In the present multi-center 
observational study, the effects of nebivolol, a selective betal-receptor blocking agent 
which enhances endothelial nitric oxide (NO) release, were investigated in hypertensive 
patients with Hypedipidemia (HLP) and coronary artery disease (CAD). 
Methods: 8682 patients were included, average age 56.3+12.0 years, 53.8% males. Of 
these 3084 (35.5%) had HLP, 377 (4.3%) had additionally CAD. Besides systolic and 
diastolic blood pressure (BP), serum lipid values were measured before and after an 
average 59.7 days of treatment with nebivolol. According to the treating physicians co- 
medication and dietary habits remained unchanged. 
Results: The systolic and diastolic BP reduced in mean by 26.6+14.4 and 13.6_+9.0 
mmHg respectively. The LDL-levels decreased significantly from 156.7+42.5 to 
145.4+37.9 mg/dl (p<0,05). The HDL-levels increased significantly on the other hand 
under treatment from 48.8+19.1 to 48.8±16.3 mg/dl (p<0,05). 
Conclusions: Treatment with nebivolol ead to an increase in HDL-levels and a decrease 
in LDL-leve~s. The findings can only partly be explained by the BP lowering effect of 
nebivoloL A possible enhanced endothelial NO release, which has been shown for nebiv- 
olol previously, could explain the lipid lowering effects of this drug. Further studies are 
required to underline these results. 
1011-96A Effects of L ipid-Lowering Therapy With Flbretes on 
Endothelial Function In Patients With Type 2 Diabetes 
Mellltus 
Hideki Watanabe. Kunio Nakagawa, Maseaki Kakihana, KINU Medical Association 
Hospital, Mitsukaido, Japan, Ibaraki Prefectural University of Health Sciences, Aml, 
Japan. 
Dyslipidemia characterized by elevated triglyceride (TG) and reduced HDL-cholesterol 
(HDL-C) has been reported in patients with type 2 diabetes mellitus (DM). To evaluate 
effects of fibrates on endothelial functio, twenty-four type 2 diabetic patients with ele- 
vated TG (TG>150 mg/dL) were randomized to receive either fibrates (bezafibrate: B 
group, n=7; fenofibrate: F group, n=5) or placebo (n=12). By using ultrasound with a 7.5- 
MHz transducer, the brachial artery diameter was measured at rest and during reactive 
hyperemia (flow-mediated ilatation, FMD), and before and after 0.3 mg of sublingual 
nitroglycerin (nitroglycerin-induced dilatation, NID). These measurements were per- 
formed in 12-hour overnight fasting condition at baseline and after 3 months of the treat- 
ment. At baseline, there was no difference in lipid parameters, fasting glucose level, 
HbAlc, brachial artery diameters, %FMD (%incraase in diameter during hyperemia), and 
%NID (%increase in diameter after NTG) among three groups. After 3 months, triglycer- 
ide and LDL-C levels were significantly decreased, and HDL-C level was significantly 
increased in the fibrates groups (TG: B group, -38%, F group -45%; LDL-C: B group, - 
11%, F group -14%; HDL-C: B group, +18%, F group +19%). %FMD was improved after 
3 months of treatment with fibrates. On the other hand, %NID, fasting glucose level and 
HbAlc did not change after 3 months. Conclusion: Lipid-lowering therapy with fibrates 
might restore endothelial function in patients with type 2 DM. 
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1031-82 Sensitivity to Endothelin Is Increased in the Endothelial 
Dysfunction of Epicardiel Coronary Arteries in Left 
Vsntricular Hypertrophy in Swine 
Fanny Desiardins, Olivier Malo, Marie-Pierre Mathieu, Michel Carrier, Louis P. Perrault, 
Montreal Heart Institute, Montreal, Quebec, Canada. 
Background: We have recently demonstrated that NO-mediated endothelium-dependent 
relaxations are impaired in left ventricular hypertrophy (LVH) after 60 days of pressure 
ovedoad produced by aortic stenosis. Whether increased endothelium-dependent con- 
tractions contributes to this endothelial dysfunction is unknown. 
Objective: The aim of this project was to assess the sensitivity of endothelium-depondant 
vasoconstrictor ET-1 and endothelium-independent serotonin (5-HT) on the vascular 
smooth muscle of coronary artedes of swine submitted to 60 days of aortic banding. The 
plasmatic levels of the NO2-/NO3- ratio was measured to assess the production of NO in 
this model, 
Methods: Banding was performed through a left thoracotomy using umbilical tapes for 60 
days period, A minimal gradient of 15 mmHg was created by an aortic banding 3 cm 
above the coronary ostia. Development of LVH was documented by sedal echocardio- 
grams, Endothelium-dependent and independent contractions to ET-1 and 5-HT were 
studied by constructing dose-response curves in organ chamber experiments to evaluate 
the increase sensitivity to vasoconstriction (in the presence of indomethacin and propre- 
nolol), The plasma level of NO2-/NO3- was measured with a NO analyzer. 
Results: 60 days after aortic banding, there is an increase in endothelium-dependent 
contractions to ET-1 (P<0,05) and to 5-HT (P<0,05) compared to the control group. 
There is also a decrease in the NO2-/NO3- ratio 60 days after aortic stenesis (P<0,05), 
Conclusion: With the development of LVH secondary to aortic stenosis, the sensitivity of 
the vascular smooth muscle to ET-1 is increased as well as the sensitivity to 5-HT in cor- 
onary arteries. Decreased production of NO, could contribute to the increased tendency 
of epicardial coronary arteries to vasoconstriction. The dual mechanisms of endothelial 
dysfunction of decreased production of endothelial NO and increased sensitivity to vaso- 
constrictors may impair myocardial function by rendering cardiac muscle more suscepti- 
ble to ischemic injury. Pharmacological therapy should be both aimed at increasing 
endothelial NO and inhibiting ET-t to improve endothelial function of coronary arteries in 
LVH. 
1031-83 Chronic Selective Endothel in A Receptor Antagonism 
Preserves Myocardial Perfusion in Experimental 
Hypercholesterolemia 
Piero O. Booetti. Patricia J. Best, Martin Rodriguez-Porcel, David R. Holmes, Jr., Lilach 
O. Lerman, Amir Lerman, Division of Cardiovascular Diseases and Division of 
Hypertension, Mayo Clinic, Rochester, Minnesota, 
Expedmental hypercholesterolemia (HC) leads to coronary endothelial dysfunction, 
endothelin activation, increased vascular permeability, and attenuation of the myocardial 
perfusion (MP) response to increased myocardial demand, Chronic administration of 
endothelin A receptor (ETA) antagonists preserves coronary endothelial function in HC. 
However, whether this translates into preservation of MP is still unknown. Thus, the cur- 
rent study was designed to test the hypothesis that chronic ETA antagonism would pre- 
serve MP in HC. 
Methods: Pigs were randomized to 3 experimental groups: normal diet (N; n=7), high 
cholesterol diet (HC; n=7) and HC diet plus ABT-627, a selective ETA antagonist 
(HC+ABT-627; n=7) for 12 weeks, Electron beam computed tomography of the heart was 
performed before and during intravenous infusion of adenosine to calculate MP (ml/min/g 
myocardial tissue) and microvascular permeability index (PI; arbitrary units). 
Results: LDL-cholesterol was significantly and similarly increased in the HC and 
HC+ABT-627 group compared to N. As shown in the table, ABT-627 improved MP and 
preserved PI during adenosine infusion in HC. 
Conclusion: The current study demonstrates that chronic ETA antagonism with ABT-627 
preserves MP response to increased myocardial demand in HC in association with pres- 
ervation of microvascular permeability. This suggests a role for the endogenous endothe- 
lin system in the regulation of MP in pathophysiological states associated with 
endothelial dysfunction. 
Myocardial perfualon end mlcroveecular permeability Index at baseline 
and in response to adenosine 
N HC HC+ABT-627 
MP baseline 0.90+/-0. t 0.95+/-0.1 1 .o3+/-0.1 
MP adenosine 1.30+/-0.1 * 0.92+/-0.1 1.33+/-0.1 * 
% Change of MP to adenosine +48+/-7 -2+/-41" +29+/-6 
PI baseline 1.54+/-0.1 1 .34+/ -0 .2  1.62+/-0.1 
PI adenosine 1.73+/-0.2 2.26+/-0.2* 1.82+#0.1 
% Change of PI to adenosine +11+/-5 +78+/-131" +15+/-7 
* p < 0.001 vs baseline 
t P < 0.005 vs N and/or HC+S 
